These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31176537)

  • 1. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
    Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
    Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
    Kirshenboim Z; Dan Lantsman C; Appel S; Klug M; Onn A; Truong MT; Marom EM
    Lung Cancer; 2023 Aug; 182():107265. PubMed ID: 37327593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
    Dunlap NE; Yang W; McIntosh A; Sheng K; Benedict SH; Read PW; Larner JM
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1071-7. PubMed ID: 22898383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study.
    Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Umeoka S; Nakamoto Y; Mizowaki T; Togashi K; Hiraoka M
    Eur J Radiol; 2017 Jul; 92():58-63. PubMed ID: 28624021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
    Zhang X; Liu H; Balter P; Allen PK; Komaki R; Pan T; Chuang HH; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1558-65. PubMed ID: 22572078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
    Huang YS; Chen JL; Hsu FM; Huang JY; Ko WC; Chen YC; Jaw FS; Yen RF; Chang YC
    J Magn Reson Imaging; 2018 Jan; 47(1):191-199. PubMed ID: 28480541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
    Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
    Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.
    Chang JY; Balter PA; Dong L; Yang Q; Liao Z; Jeter M; Bucci MK; McAleer MF; Mehran RJ; Roth JA; Komaki R
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):967-71. PubMed ID: 18954709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW; Videtic GM; Djemil T; Stephans KL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.
    Kennedy WR; Gabani P; Nikitas J; Robinson CG; Bradley JD; Roach MC
    Radiother Oncol; 2020 Jan; 142():230-235. PubMed ID: 31481272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.
    Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF
    Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Histologic Basis for the Efficacy of SBRT to the lung.
    Woody NM; Stephans KL; Andrews M; Zhuang T; Gopal P; Xia P; Farver CF; Raymond DP; Peacock CD; Cicenia J; Reddy CA; Videtic GM; Abazeed ME
    J Thorac Oncol; 2017 Mar; 12(3):510-519. PubMed ID: 28017592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.
    Tyagi N; Cloutier M; Zakian K; Deasy JO; Hunt M; Rimner A
    J Appl Clin Med Phys; 2019 Jan; 20(1):284-292. PubMed ID: 30421496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
    Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
    J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Peulen H; Mantel F; Guckenberger M; Belderbos J; Werner-Wasik M; Hope A; Giuliani M; Grills I; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):134-41. PubMed ID: 27325481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Ronden MI; van Sörnsen de Koste JR; Johnson C; Slotman BJ; Spoelstra FOB; Haasbeek CJA; Blom G; Bongers EM; Warner A; Ward A; Palma D; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):115-121. PubMed ID: 29102278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.